Watch Ticker

Kura Oncology, Inc.

Go to Kura Oncology, Inc. Website

$6.36

0.00 (0.00%)

Live

Previous Close

$6.36

Day Range

$0 - $0

Previous Day Range

$6.27 - $6.4899

Market Cap

$547.2 million USD

Day Vol.

Previous Day Vol.

1.6 million

Currency

USD

Primary Exchange

Nasdaq

Kura Oncology Inc is a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the treatment of cancer. The company's pipeline consists of small molecule drug candidates targeting cancer signaling pathwa...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Kura Oncology and Kyowa Kirin Report Positive Pivotal Ziftomenib Monotherapy Data at 2025 ASCO Annual Meeting

Kura Oncology and Kyowa Kirin announced positive pivotal data from the KOMET-001 Phase 2 trial of ziftomenib, an investigational menin inhibitor, in patients with relapsed/refractory NPM1-mutant acute myeloid leukemia. The data showed a 23% complete remission/complete remission with partial hematological recovery rate and a favorable safety profile.

Related tickers: KURA.

Read Full Article

N/A - Kura Oncology and Kyowa Kirin Announce FDA Acceptance and Priority Review of New Drug Application for Ziftomenib in Adults with Relapsed or Refractory NPM1-Mutant AML

Kura Oncology and Kyowa Kirin announced that the FDA has accepted their New Drug Application for ziftomenib, a menin inhibitor, for the treatment of adult patients with relapsed or refractory NPM1-mutant acute myeloid leukemia. The application has been granted Priority Review with a target action date of November 30, 2025.

Related tickers: KURA.

Read Full Article

Trending Tickers

Please sign in to view